InfuSystem Holdings, Inc. (INFU)

Price$9.24

Value ScoreB

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-8.36%

Price vs S&P 500 (4W)9.88%

VGM Score65.51

Market Capitalization$186.48M

P/E Ratio (Annual)28.14x

All Metrics

P/CF (Annual)7.64x

Book Value / Share (Quarterly)$2.91

P/TBV (Annual)3.62x

Revenue Growth (3Y)9.28%

Cash Flow / Share (Quarterly)$0.82

Price vs S&P 500 (YTD)-5.15%

Gross Margin (TTM)56.75%

Net Profit Margin (TTM)5.56%

EPS (TTM)$0.38

10-Day Avg Trading Volume0.15M

EPS Excl Extra (TTM)$0.38

Revenue Growth (5Y)8.05%

EPS (Annual)$0.31

ROI (Annual)8.61%

Gross Margin (Annual)55.98%

Net Profit Margin (5Y Avg)1.69%

Cash / Share (Quarterly)$0.10

P/E Basic Excl Extra (TTM)23.57x

Revenue Growth QoQ (YoY)-2.97%

EPS Growth (5Y)-17.01%

P/E Normalized (Annual)28.14x

ROA (Last FY)6.59%

Revenue Growth TTM (YoY)3.50%

EBITD / Share (TTM)$0.71

ROE (5Y Avg)4.06%

Operating Margin (TTM)9.05%

Cash Flow / Share (Annual)$0.78

P/B Ratio3.17x

P/B Ratio (Quarterly)3.17x

Net Income / Employee (Annual)$14,400

EV / Revenue (TTM)1.43x

Net Interest Coverage (TTM)9.18x

ROA (TTM)7.93%

EPS Growth QoQ (YoY)126.74%

EV / EBITDA (TTM)13.63x

EPS Incl Extra (Annual)$0.31

Current Ratio (Annual)1.80x

Quick Ratio (Quarterly)1.80x

3-Month Avg Trading Volume0.15M

52-Week Price Return55.82%

EV / Free Cash Flow (Annual)12.98x

P/E Incl Extra (TTM)23.57x

Revenue / Employee (TTM)$308,900

Tangible BV / Share (Quarterly)$2.58

P/S Ratio (Annual)1.30x

Asset Turnover (Annual)1.43x

52-Week High$11.04

Operating Margin (5Y Avg)4.18%

EPS Excl Extra (Annual)$0.31

CapEx CAGR (5Y)-12.48%

Tangible BV CAGR (5Y)11.28%

26-Week Price Return-0.43%

Quick Ratio (Annual)1.53x

13-Week Price Return-4.55%

Total Debt / Equity (Annual)0.34x

Current Ratio (Quarterly)2.14x

Enterprise Value$204.02M

Revenue / Share Growth (5Y)8.68%

Asset Turnover (TTM)1.43x

Book Value / Share Growth (5Y)7.16%

Revenue / Employee (Annual)$311,100

Inventory Turnover (Annual)10.59x

Pretax Margin (Annual)7.41%

Cash / Share (Annual)$0.16

3-Month Return Std Dev49.29%

Gross Margin (5Y Avg)54.82%

Net Income / Employee (TTM)$17,200

EBITDA CAGR (5Y)0.18%

EBITDA Interim CAGR (5Y)-0.16%

ROE (Last FY)11.56%

Net Interest Coverage (Annual)10.68x

EPS Basic Excl Extra (Annual)$0.31

P/FCF (TTM)10.74x

Receivables Turnover (TTM)5.72x

EV / Free Cash Flow (TTM)12.37x

Total Debt / Equity (Quarterly)0.33x

EPS Incl Extra (TTM)$0.38

Receivables Turnover (Annual)6.25x

ROI (TTM)10.12%

P/S Ratio (TTM)1.31x

Pretax Margin (5Y Avg)2.80%

Revenue / Share (Annual)$6.80

Tangible BV / Share (Annual)$2.50

Forward P/E21.74x

Free OCF CAGR (5Y)36.11%

Price vs S&P 500 (52W)31.45%

P/E Ratio (TTM)23.57x

EPS Growth TTM (YoY)156.91%

Year-to-Date Return3.01%

5-Day Price Return3.24%

EPS Normalized (Annual)$0.31

ROA (5Y Avg)2.24%

Net Profit Margin (Annual)4.62%

Month-to-Date Return1.87%

Cash Flow / Share (TTM)$0.61

EBITD / Share (Annual)$0.67

EPS Growth (3Y)632.25%

Operating Margin (Annual)8.31%

LT Debt / Equity (Annual)0.34x

P/CF (TTM)7.90x

ROI (5Y Avg)2.87%

P/E Excl Extra (TTM)23.57x

LT Debt / Equity (Quarterly)0.33x

EPS Basic Excl Extra (TTM)$0.38

P/TBV (Quarterly)3.58x

P/B Ratio (Annual)3.18x

Inventory Turnover (TTM)10.33x

Pretax Margin (TTM)8.28%

Book Value / Share (Annual)$2.84

Price vs S&P 500 (13W)-12.80%

Net Margin Growth (5Y)-23.64%

Beta1.44x

P/FCF (Annual)11.86x

Revenue / Share (TTM)$6.82

ROE (TTM)14.00%

52-Week Low$5.38

vGradeB

gGradeC

mGradeB

vgmGradeB

Show chart for

Earnings Surprise History

Q1 260.05est. 0.03

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.18

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
INFUInfuSystem Holdings, Inc.	B	C	B	$9.24
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

InfuSystems Holdings Inc is a healthcare services provider offering durable medical equipment (DME), consumables, and related support services to patients and healthcare providers. The company operates two segments: Patient Services (primary revenue driver) providing DME supply, order fulfillment, 24/7 clinical support, and insurance billing services; and Device Solutions offering equipment rentals and sales with biomedical support. The integrated platform manages the complete DME care cycle, combining supply, logistics, and clinical support services.